BioSpace News Archive

Ipsen, a global specialty-driven biopharmaceutical company, announced the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024.

Ikerian AG and its subsidiary, RetinAI U.S. Inc. a leading developer of software solutions for medical image and data management

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy, announced that results of its EfficAPSI real-world study evaluating the impact of Stallergenes Greer liquid sublingual AIT on asthma onset and evolution in patients with allergic rhinitis have been published in the Lancet Regional Health-Europe.

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces that the Company has been issued a patent by the European Patent Office protecting its T cell receptor targeting NY-ESO-1, a well-recognized and validated cancer-testis antigen, which is expressed in multiple tumor types.

Isarna Therapeutics announced upcoming oral presentations at the OIS Retina Innovation Summit on May 4th and the Association for Research in Vision and Ophthalmology Meeting on May 7th, both in Seattle, WA.

Smart Immune announces the treatment of the first patient in the third and final dose cohort of the dose-escalation stage in its ReSET-02 trial.

Verona Pharma plc, announces eight posters, including two mini oral symposia, on additional analyses from its successful Phase 3 ENHANCE studies with ensifentrine for the treatment of chronic obstructive pulmonary disease will be presented at the American Thoracic Society International Conference 2024.

Medigene AG presented superior T cell receptor engineered T cell functionality upon combination of optimal affinity 3S TCRs with the PD1-41BB costimulatory switch protein at the 7th International Neoantigen Summit held in Amsterdam, Netherlands from April 29 - May 1, 2024.

Spago Nanomedical strengthens management by the appointment of Birgitta Rembratt Svensson as Head of CMC & Supply.

Corin Group, a pioneer in orthopaedic innovation, announced the successful completion of first cases using the Apollo™ platform and ApolloKnee™ software for robotic-assisted total knee arthroplasty.